Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
about
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated regionAdenomyosis and its impact on women fertilityThe coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compoundVascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the ratIn vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patientsThe effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.Mechanistic and therapeutic implications of angiogenesis in endometriosis.ESTROGEN REPLACEMENT THERAPY FOR STROKE.Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus.Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsBreast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer.Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women.Estrogen receptor interaction with estrogen response elementsBevacizumab in the treatment of patients with advanced breast cancer: where have we landed?Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomasRoles of main pro- and anti-angiogenic factors in tumor angiogenesisAssociations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis.Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumabInfiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence.Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinasesAssociation of vascular endothelial growth factor (VEGF) +405 g>c polymorphism with endometriosis in an Iranian populationCirculating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosisEstrogen-growth factor interactions and their contributions to neurological disordersEstrous cycle modulates ovarian carcinoma growth.Influence of ovarian endometrioma on expression of steroid receptor RNA activator, estrogen receptors, vascular endothelial growth factor, and thrombospondin 1 in the surrounding ovarian tissues.Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.The use of a whole animal biophotonic model as a screen for the angiogenic potential of estrogenic compoundsMolecular and cellular events during blastocyst implantation in the receptive uterus: clues from mouse modelsVascular endothelial growth factor, transforming growth factor-alpha, and estrogen receptors: possible cross-talks and interactions.The role of steroid hormones on the regulation of vascular endothelial growth factor.Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue.
P2860
Q24530625-422D0813-E99F-4796-949D-0CF0B36D4BDFQ26786756-A6B8B417-28BD-4E7B-BC8C-2761CF0639AEQ28473733-78FF3CD0-66D8-4309-B3E5-B36884262654Q28570072-534BAF7D-65A5-4DD3-8C03-CC4106F64624Q33325668-92A2F548-1E5D-490E-8262-18E001AC7E55Q33372962-36D6B134-4533-47AA-B36B-D673A65FBBABQ33591382-BA85B682-C737-4084-9239-38F685139B4FQ33716837-B3E660A2-F19C-4E5C-AC40-A0CC3F863A41Q33734466-A5FC844F-0093-46C3-9516-F0BEC16571E2Q33770684-1C1678C2-0758-4659-8349-5EEB26CB382FQ33779409-8E763833-D141-493F-A2DD-4214B0B16886Q33840436-1824B767-3E85-40B8-9E57-BBD5B8530B2FQ34006777-1991849A-AFF9-4C5B-9698-36DF9966F1FEQ34044998-C540368B-B880-4BA2-B408-3F690EDC1E18Q34082909-3E866983-2527-44C2-8689-28A7169AE883Q34083767-19D09090-BC84-4215-B5A5-79FF0E668DDBQ34095952-15D3ABC4-D24C-4849-A555-848EFF75ED78Q34219967-CE6C03F5-9311-47A3-B2F1-12D8A64B7354Q34226420-A5EF2F05-1137-4DAE-9399-4F2BA973EA4FQ34307898-119F04D7-8F95-41C0-A05F-7C70BB12EF44Q35076287-E250F7C5-696C-4DA8-A9CE-E533A0FBD92DQ35587840-7AC177AE-5138-449C-BFDD-8093E7F140B1Q35668936-22F071E9-20C6-4465-935C-333F79C57A28Q35877155-C4B095DB-B0DE-4623-A492-F794EB92513CQ36286698-FAF4DEF5-813C-4F49-82A1-4AA6BA068927Q36646282-2B77F24B-CD81-403F-8C6E-5EF987515151Q36670997-AF2B8C00-DF7F-4C1E-8989-A3570776CB56Q36714092-FFA858A4-A9D2-4E34-923D-A9F5E9A837D0Q36796731-5871D90D-F6AD-4469-912C-7948452264CAQ37035051-324A286E-1B13-4E97-966E-334E8E3E0AEDQ37180102-C8440EEF-DFD6-424A-8969-2732901ACD09Q37242949-71C3D292-BDD8-46C3-A69B-C190B8AC877CQ37345175-2E861C04-7C42-47DD-B71C-E46F48B350DDQ37430130-BFCD8CB3-59FE-466B-9FE0-D4B94A162E5DQ37493335-9ACA44B5-46D9-486A-9289-D30F0A1F8539Q37730253-54899292-05C9-411F-A9E4-67D9FB743EBBQ39389033-3A977339-4FB6-4A1A-A2B9-4225E25AA62EQ42794674-7833D693-2AAF-44B8-88F5-3F7168BED4AFQ42855909-1185E518-E512-497A-90B7-CB20E3445708Q46727445-2CFE4B09-BA2A-4890-B9C4-3BFC3C120512
P2860
Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Identification of functional e ...... lar endothelial growth factor.
@en
type
label
Identification of functional e ...... lar endothelial growth factor.
@en
prefLabel
Identification of functional e ...... lar endothelial growth factor.
@en
P2093
P1433
P1476
Identification of functional e ...... lar endothelial growth factor.
@en
P2093
P304
P407
P577
2000-06-01T00:00:00Z